NCCN 2010 Congress Series™: Gastrointestinal Cancers - Event Summary | Online Registration by Cvent

NCCN 2010 Congress Series™: Gastrointestinal Cancers

Summary

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines™ for Colorectal, Hepatocellular, Pancreatic, and Gastric/Esophageal Cancers, collectively Gastrointestinal Cancers. Participants will learn how to implement the recommendations within the NCCN Guidelines into their practice and gain a clear understanding of the most up-to-date treatment recommendations for colorectal, hepatocellular, pancreatic, and gastric/esophageal cancers.

The impact of these cancers is quite significant. Colorectal cancer is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States. Hepatobiliary cancers are highly fatal cancers. High-risk factors for the development of hepatocellular carcinoma (HCC), the most common of the hepatobiliary malignancies, include hepatitis B and/or hepatitis C viral infection, particular comorbidities or conditions, and certain external sources. Pancreatic cancer is the fourth most common cause of cancer-related death among U.S. men. Its peak incidence occurs most often in older adults as most people diagnosed with pancreatic cancer are in their 70s and 80s. Upper gastrointestinal (GI) tract cancers originating in the esophagus, stomach, and gastroesophageal (GE) junctions constitute a major health problem around the world. Management of these patients continues to be a challenging area in oncology.


Details
This is a series of webinars that will be presented during this date range. Please proceed to "Schedule" to see complete list of offerings with dates/times.


When Thursday, November 4, 2010 - Thursday, December 16, 2010

NCCN 2010 Congress Series™: Gastrointestinal Cancers - Event Summary | Online Registration by Cvent